Scope of Services

Business Cases & VC-Readiness

Business Cases & VC-Readiness

Date

Date

#

Business Cases & VC Readiness

We make scientific innovation investable.

We translate scientific, clinical, and commercial assumptions into a coherent decision-making logic grounded in market realities, evidence, and risks. This creates a robust foundation for financing and valuation processes that can also withstand rigorous investor scrutiny.

Mark Thomet, Co-Founder of Excellere, is an expert in business cases, VC readiness and investor logic in the life sciences sector

Our Approach

Excellere structures decision-making, financing, and valuation around clear investor-releant criteria.

Our goal is not to optimize narratives, but to build robust decisions foundations that lead to sustainable financing outcomes. We:


  • evaluate business models based on realistic assumptions

  • address weaknesses transparently and in a solution-oriented manner

  • strengthen the negotiating position of management teams and founders in critical financing discussions.

Typical decision-making situations

Specific situations where decision quality makes the difference.

Startups and scaleups that


  • are preparing for institutional financing rounds

  • want to build a robust, investment-ready business case

  • must develop an equity story that withstands commercial due diligence

  • seek structured sparring for critical valuation and negotiation situations

Objective: 

Decision-ready materials, a strong negotiating position, and a higher probability of closing.


Investors


  • want to evaluate external assets or acquisition targets in a structured manner

  • require robust decision foundations beyond purely financial models

  • want to quantify commercial, market access, and development risks realistically

Objective: 

Robust valuations and transparent, well-documented decision foundations.

Services for Business Cases & VC Readiness

Structured decision-making foundations for investment and financing.

BUSINESS CASE DEVELOPMENT
Focus

Realistic, scenario-based business cases as a reliable foundation for strategic investment and financing decisions.

Key Questions
  • How robust are market potential, pricing, and uptake assumptions under realistic scenarios?

  • Which assumptions are value-driving, and which are critical from a risk perspective?

  • How resilient is the case across worst-, base-, and best-case scenarios?


COMMERCIAL DUE DILIGENCE
Focus

Independent assessment of assets and companies from a commercial and market access perspective, with a clear focus on value drivers and risk structures.

Key Questions
  • Is the targeted value potential achievable under realistic market and reimbursement assumptions?

  • Where are the key commercial or structural risk factors?

  • Does the management narrative withstand a structured due diligence assessment?


FUNDRAISING & INVESTOR PITCH
Focus

Translating complex scientific and commercial inputs into a consistent equity story and a defensible negotiating position.

Key Questions
  • Which narratives remain robust across multiple financing rounds and due diligence processes?

  • How can risks be addressed transparently without undermining credibility?

  • How are management teams prepared for critical questions on market, evidence, regulatory, and model assumptions?


FINANCIAL MODELING
Focus

Transparent, decision-oriented financial models as a shared foundation for management and investors decisions.

Key Questions
  • How consistent are assumptions across the model, presentations, and investor discussions?

  • Which sensitivities and scenarios are decision-relevant and must be actively managed?

  • Which KPIs truly drive investor decisions?

Contact

Whenconcretedecisionsarerequired,wediscussthemtogether.

Whenconcretedecisionsarerequired,wediscussthemtogether.

We assess your situation in a structured manner and define which next steps are appropriate, as well as where the key risks and value drivers lie.

Contact

Whenconcretedecisionsarerequired,wediscussthemtogether.

We assess your situation in a structured manner and define which next steps are appropriate, as well as where the key risks and value drivers lie.

© 2026 Excellere LifeScience Consulting GmbH. All rights reserved.

© 2026 Excellere LifeScience Consulting GmbH. All rights reserved.

© 2026 Excellere LifeScience Consulting GmbH. All rights reserved.